CEBPZ and Alzheimer disease: A rise in ROS level could contribute to the CBF decrease in AD by triggering Ca2+ entry through mural cell CaVs (Fig. 4a,b), so we tested whether CBF in AD mice can be modulated by blocking microglial/PVM production of ROS via NOX2.